Inflammatory biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), and procalcitonin, often used in critically ill patients, have been proposed as risk stratification tools in the context of COVID-19 [3,4,5]. The gene discussed is IL6; the disease is COVID-19.